ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Stomach Cancer and Gastric Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-35F7956
Home | Market Reports | Health| Health Conditions| Cancer
Global and United States Stomach Cancer and Gastric Cancer Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Stomach Cancer and Gastric Cancer Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35F7956
Report
October 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ipsen Pharma
Merck& Co. Inc
Bristol Myers Squibb Company
Eli Lilly
Roche
Novartis
Bayer
Celltrion
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co Ltd

Stomach Cancer and Gastric Cancer Treatment - Market Size

The global market for Stomach Cancer and Gastric Cancer Treatment was estimated to be worth US$ 3948 million in 2023 and is forecast to a readjusted size of US$ 9059.7 million by 2030 with a CAGR of 12.6% during the forecast period 2024-2030

Stomach Cancer and Gastric Cancer Treatment - Market

Stomach Cancer and Gastric Cancer Treatment - Market

Stomach cancer is the fifth most common cancer in the world
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Stomach Cancer and Gastric Cancer Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stomach Cancer and Gastric Cancer Treatment by region & country, by Type, and by Application.
The Stomach Cancer and Gastric Cancer Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stomach Cancer and Gastric Cancer Treatment.
Market Segmentation

Scope of Stomach Cancer and Gastric Cancer Treatment - Market Report

Report Metric Details
Report Name Stomach Cancer and Gastric Cancer Treatment - Market
Forecasted market size in 2030 US$ 9059.7 million
CAGR 12.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Programmed Cell Death Protein 1 (PD-1) Inhibitors
  • Human Epidermal Growth Factor Receptor (HER2) Antagonists
  • Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
  • Others
Segment by Application
  • Hospitals
  • Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ipsen Pharma, Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly, Roche, Novartis AG, Bayer AG, Celltrion Inc., TAIHO PHARMACEUTICAL CO., LTD., Jiangsu Hengrui Medicine Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Stomach Cancer and Gastric Cancer Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Stomach Cancer and Gastric Cancer Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Stomach Cancer and Gastric Cancer Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Stomach Cancer and Gastric Cancer Treatment - Market size in 2030?

Ans: The Stomach Cancer and Gastric Cancer Treatment - Market size in 2030 will be US$ 9059.7 million.

Who are the main players in the Stomach Cancer and Gastric Cancer Treatment - Market report?

Ans: The main players in the Stomach Cancer and Gastric Cancer Treatment - Market are Ipsen Pharma, Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly, Roche, Novartis AG, Bayer AG, Celltrion Inc., TAIHO PHARMACEUTICAL CO., LTD., Jiangsu Hengrui Medicine Co., Ltd.

What are the Application segmentation covered in the Stomach Cancer and Gastric Cancer Treatment - Market report?

Ans: The Applications covered in the Stomach Cancer and Gastric Cancer Treatment - Market report are Hospitals, Clinics

What are the Type segmentation covered in the Stomach Cancer and Gastric Cancer Treatment - Market report?

Ans: The Types covered in the Stomach Cancer and Gastric Cancer Treatment - Market report are Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, Others

1 Market Overview
1.1 Stomach Cancer and Gastric Cancer Treatment Product Introduction
1.2 Global Stomach Cancer and Gastric Cancer Treatment Market Size Forecast
1.3 Stomach Cancer and Gastric Cancer Treatment Market Trends & Drivers
1.3.1 Stomach Cancer and Gastric Cancer Treatment Industry Trends
1.3.2 Stomach Cancer and Gastric Cancer Treatment Market Drivers & Opportunity
1.3.3 Stomach Cancer and Gastric Cancer Treatment Market Challenges
1.3.4 Stomach Cancer and Gastric Cancer Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Stomach Cancer and Gastric Cancer Treatment Players Revenue Ranking (2023)
2.2 Global Stomach Cancer and Gastric Cancer Treatment Revenue by Company (2019-2024)
2.3 Key Companies Stomach Cancer and Gastric Cancer Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Stomach Cancer and Gastric Cancer Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Stomach Cancer and Gastric Cancer Treatment
2.6 Stomach Cancer and Gastric Cancer Treatment Market Competitive Analysis
2.6.1 Stomach Cancer and Gastric Cancer Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Stomach Cancer and Gastric Cancer Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Programmed Cell Death Protein 1 (PD-1) Inhibitors
3.1.2 Human Epidermal Growth Factor Receptor (HER2) Antagonists
3.1.3 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
3.1.4 Others
3.2 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type
3.2.1 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Stomach Cancer and Gastric Cancer Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Stomach Cancer and Gastric Cancer Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application
4.2.1 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Stomach Cancer and Gastric Cancer Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Stomach Cancer and Gastric Cancer Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region
5.1.1 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2019-2024)
5.1.3 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2025-2030)
5.1.4 Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
5.2.2 North America Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
5.3.2 Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
5.5.2 South America Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value
6.3 United States
6.3.1 United States Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.3.2 United States Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.4.2 Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.5.2 China Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.6.2 Japan Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.7.2 South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019-2030
6.9.2 India Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Stomach Cancer and Gastric Cancer Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ipsen Pharma
7.1.1 Ipsen Pharma Profile
7.1.2 Ipsen Pharma Main Business
7.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.1.4 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Ipsen Pharma Recent Developments
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Profile
7.2.2 Merck & Co., Inc. Main Business
7.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.2.4 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Merck & Co., Inc. Recent Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Profile
7.3.2 Bristol-Myers Squibb Company Main Business
7.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.3.4 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Eli Lilly Recent Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Profile
7.4.2 Eli Lilly Main Business
7.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.4.4 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Eli Lilly Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.5.4 Roche Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 Novartis AG
7.6.1 Novartis AG Profile
7.6.2 Novartis AG Main Business
7.6.3 Novartis AG Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.6.4 Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis AG Recent Developments
7.7 Bayer AG
7.7.1 Bayer AG Profile
7.7.2 Bayer AG Main Business
7.7.3 Bayer AG Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.7.4 Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Bayer AG Recent Developments
7.8 Celltrion Inc.
7.8.1 Celltrion Inc. Profile
7.8.2 Celltrion Inc. Main Business
7.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.8.4 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Celltrion Inc. Recent Developments
7.9 TAIHO PHARMACEUTICAL CO., LTD.
7.9.1 TAIHO PHARMACEUTICAL CO., LTD. Profile
7.9.2 TAIHO PHARMACEUTICAL CO., LTD. Main Business
7.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.9.4 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
7.10 Jiangsu Hengrui Medicine Co., Ltd.
7.10.1 Jiangsu Hengrui Medicine Co., Ltd. Profile
7.10.2 Jiangsu Hengrui Medicine Co., Ltd. Main Business
7.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
7.10.4 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Stomach Cancer and Gastric Cancer Treatment Industrial Chain
8.2 Stomach Cancer and Gastric Cancer Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Stomach Cancer and Gastric Cancer Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Stomach Cancer and Gastric Cancer Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Ipsen Pharma
Merck& Co. Inc
Bristol Myers Squibb Company
Eli Lilly
Roche
Novartis
Bayer
Celltrion
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co Ltd
List of Tables
    Table 1. Stomach Cancer and Gastric Cancer Treatment Market Trends
    Table 2. Stomach Cancer and Gastric Cancer Treatment Market Drivers & Opportunity
    Table 3. Stomach Cancer and Gastric Cancer Treatment Market Challenges
    Table 4. Stomach Cancer and Gastric Cancer Treatment Market Restraints
    Table 5. Global Stomach Cancer and Gastric Cancer Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Stomach Cancer and Gastric Cancer Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Stomach Cancer and Gastric Cancer Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Stomach Cancer and Gastric Cancer Treatment
    Table 10. Global Stomach Cancer and Gastric Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Stomach Cancer and Gastric Cancer Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Stomach Cancer and Gastric Cancer Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Stomach Cancer and Gastric Cancer Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Stomach Cancer and Gastric Cancer Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Ipsen Pharma Basic Information List
    Table 32. Ipsen Pharma Description and Business Overview
    Table 33. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Ipsen Pharma (2019-2024)
    Table 35. Ipsen Pharma Recent Developments
    Table 36. Merck & Co., Inc. Basic Information List
    Table 37. Merck & Co., Inc. Description and Business Overview
    Table 38. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Merck & Co., Inc. (2019-2024)
    Table 40. Merck & Co., Inc. Recent Developments
    Table 41. Bristol-Myers Squibb Company Basic Information List
    Table 42. Bristol-Myers Squibb Company Description and Business Overview
    Table 43. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Bristol-Myers Squibb Company (2019-2024)
    Table 45. Bristol-Myers Squibb Company Recent Developments
    Table 46. Eli Lilly Basic Information List
    Table 47. Eli Lilly Description and Business Overview
    Table 48. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Eli Lilly (2019-2024)
    Table 50. Eli Lilly Recent Developments
    Table 51. Roche Basic Information List
    Table 52. Roche Description and Business Overview
    Table 53. Roche Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Roche (2019-2024)
    Table 55. Roche Recent Developments
    Table 56. Novartis AG Basic Information List
    Table 57. Novartis AG Description and Business Overview
    Table 58. Novartis AG Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Novartis AG (2019-2024)
    Table 60. Novartis AG Recent Developments
    Table 61. Bayer AG Basic Information List
    Table 62. Bayer AG Description and Business Overview
    Table 63. Bayer AG Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Bayer AG (2019-2024)
    Table 65. Bayer AG Recent Developments
    Table 66. Celltrion Inc. Basic Information List
    Table 67. Celltrion Inc. Description and Business Overview
    Table 68. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Celltrion Inc. (2019-2024)
    Table 70. Celltrion Inc. Recent Developments
    Table 71. TAIHO PHARMACEUTICAL CO., LTD. Basic Information List
    Table 72. TAIHO PHARMACEUTICAL CO., LTD. Description and Business Overview
    Table 73. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of TAIHO PHARMACEUTICAL CO., LTD. (2019-2024)
    Table 75. TAIHO PHARMACEUTICAL CO., LTD. Recent Developments
    Table 76. Jiangsu Hengrui Medicine Co., Ltd. Basic Information List
    Table 77. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
    Table 78. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Stomach Cancer and Gastric Cancer Treatment Business of Jiangsu Hengrui Medicine Co., Ltd. (2019-2024)
    Table 80. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Stomach Cancer and Gastric Cancer Treatment Downstream Customers
    Table 84. Stomach Cancer and Gastric Cancer Treatment Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Stomach Cancer and Gastric Cancer Treatment Product Picture
    Figure 2. Global Stomach Cancer and Gastric Cancer Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Stomach Cancer and Gastric Cancer Treatment Report Years Considered
    Figure 5. Global Stomach Cancer and Gastric Cancer Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Stomach Cancer and Gastric Cancer Treatment Revenue in 2023
    Figure 7. Stomach Cancer and Gastric Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Programmed Cell Death Protein 1 (PD-1) Inhibitors Picture
    Figure 9. Human Epidermal Growth Factor Receptor (HER2) Antagonists Picture
    Figure 10. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Picture
    Figure 11. Others Picture
    Figure 12. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Stomach Cancer and Gastric Cancer Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Clinics
    Figure 16. Global Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Stomach Cancer and Gastric Cancer Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Stomach Cancer and Gastric Cancer Treatment Sales Value (%), (2019-2030)
    Figure 29. United States Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Stomach Cancer and Gastric Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Stomach Cancer and Gastric Cancer Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Stomach Cancer and Gastric Cancer Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. Stomach Cancer and Gastric Cancer Treatment Industrial Chain
    Figure 51. Stomach Cancer and Gastric Cancer Treatment Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stomach Cancer Drugs Market Insights Forecast to 2030
Global Gastric Cancer Drugs Market Research Report 2024
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030
Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gynaecological Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stomach Cancer Molecular Diagnostics Market Research Report 2024
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nasal Polyps Treatment Market Insights Forecast to 2030
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030
Global Gastroenterology EMR Software Market Insights Forecast to 2030
Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Helicobacter Pylori Non Invasive Testing Market Insights Forecast to 2030
Global Chronic Obstructive Pulmonary Disease COPD Treatment Market Insights Forecast to 2030
Bovine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Radiotherapy Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27U15844
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global NGS Solution for Early Cancer Screening Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24U19117
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2W15676
Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Comprehensive Medicine for Esophageal Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2N14202
Tue May 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions
OSZAR »